AskBorsa

SPINALEX results, Fiscal year 2022

Net profit, assets, equity and cash flow for Fiscal year 2022, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit35 millionEGP · +183.6% vs the same period a year earlier
Total assets688 millionEGP · −4.2% vs the same period a year earlier
Shareholders' equity599 millionEGP · +6.2% vs the same period a year earlier
Operating cash flow-40.68 millionEGP · −161.4% vs the same period a year earlier

In short

  • SPINALEX's net profit for Fiscal year 2022 was about 35 million EGP, up +183.6% from -41.88 million EGP in Fiscal year 2021.
  • Total assets at the end of Fiscal year 2022 were about 688 million EGP, and shareholders' equity about 599 million EGP.
  • Operating cash flow for Fiscal year 2022 was negative at 40.68 million EGP.
Source: the Fiscal year 2022 financial statements

Key lines against the same period a year earlier

This periodFiscal year 2021Change
Net profit35 million-41.88 million+183.6%
Gross profit55.61 million12.77 million+335.4%
Total assets688 million718 million−4.2%
Total liabilities88.7 million154 million−42.5%
Shareholders' equity599 million564 million+6.2%
Total liabilities and equity688 million718 million−4.2%
Operating cash flow-40.68 million-15.56 million−161.4%
Investing cash flow39.04 million-43.37 million+190.0%
Financing cash flow-8.86 million-8.87 million+0.1%
Net change in cash-10.51 million-58.92 million+82.2%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.

Official report (PDF)All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX